Roche’s Genentech is tackling diversity in multiple sclerosis again, this time with a focus on the Black community. Its “MS Visibility” effort, debuted in 2021, is now adding to the awareness campaign with new work that includes a set of videos featuring discussions among Black women and healthcare professionals.
“They’re incredibly inspiring Black women living with or connected to MS and they’re having just honest conversation about their experience and the unique barriers that their community faces,” said Jennifer Kim, head of neuroimmunology at Genentech marketing.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,800+ biopharma pros reading Endpoints daily — and it's free.
Health - Latest - Google News
January 30, 2023 at 11:37PM
https://ift.tt/cnOHj0Q
'The field is at a flashpoint': New Chad Mirkin-founded biotech hopes to make more effective cancer vaccines - Endpoints News
Health - Latest - Google News
https://ift.tt/MS0I8TG
Bagikan Berita Ini
0 Response to "'The field is at a flashpoint': New Chad Mirkin-founded biotech hopes to make more effective cancer vaccines - Endpoints News"
Post a Comment